|
Intercept Pharmaceuticals inc (NASDAQ: ICPT) |
|
Intercept Pharmaceuticals inc
ICPT's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Intercept Pharmaceuticals Inc growth rates, revenue grew
by 14.44 % in III. Quarter 2023 from the same quarter a year ago.
Ranking at No. 1003
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -4.76 %
Intercept Pharmaceuticals Inc faced net loss in contrast to the net income a year ago in III. Quarter 2023
• More on ICPT's Growth
|
|
Intercept Pharmaceuticals Inc realized a net loss in trailing twelve months.
Intercept Pharmaceuticals Inc realized cash reduction of $ -0.4 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.75.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.18.
• More on ICPT's Valuation
|
|
|
|
|
Intercept Pharmaceuticals Inc realized net loss in trailing twelve months.
Intercept Pharmaceuticals Inc realized cash outflow of $ -0.4per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.75.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.18.
Intercept Pharmaceuticals Inc Price to Book Ratio is at 11.05 lower than Industry Avg. of 79.45. and higher than S&P 500 Avg. of 0.01
• More on ICPT's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com